11-1584886-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001005922.1(KRTAP5-1):c.364G>A(p.Gly122Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005922.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 4AN: 108624Hom.: 0 Cov.: 16 FAILED QC
GnomAD3 exomes AF: 0.00000806 AC: 2AN: 248292Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134510
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000100 AC: 14AN: 1395516Hom.: 0 Cov.: 90 AF XY: 0.00000433 AC XY: 3AN XY: 693204
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000368 AC: 4AN: 108692Hom.: 0 Cov.: 16 AF XY: 0.0000576 AC XY: 3AN XY: 52044
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.364G>A (p.G122S) alteration is located in exon 1 (coding exon 1) of the KRTAP5-1 gene. This alteration results from a G to A substitution at nucleotide position 364, causing the glycine (G) at amino acid position 122 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at